Close
Help




JOURNAL

Drug Target Insights

Microscopic Colitis and Reproductive Factors Related to Exposure to Estrogens and Progesterone

Submit a Paper


Drug Target Insights 2013:7 53-62

Original Research

Published on 07 Oct 2013

DOI: 10.4137/DTI.S12889


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Drug Target Insights

Abstract

Microscopic colitis (MC) often debuts around or after menopause and is divided into lymphocytic- and collagenous colitis. The aim of this study was to examine whether factors influencing sex hormone levels differed between subgroups of MC as well as between patients and controls. A self-administered questionnaire about parity was completed which included questions surrounding age at first childbirth, menarche and menopause, the use of oral contraceptives, and hormonal replacement therapy. Patients with lymphocytic colitis had children less often compared to those with collagenous colitis (OR = 0.20, 95% CI = 0.05–0.86), however no differences were observed between patients with persistent or transient disease. Patients were less often older than 15 years of age at menarche (OR = 0.48, 95% CI = 0.26–0.91) and were younger at menopause (OR = 0.30, 95% CI = 0.16–0.56) compared with controls. Thus, no obvious association between factors influencing sex hormone levels and presence of MC could be found.



Downloads

PDF  (1.08 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Drug Target Insights
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
Dr Bodil Ohlsson (Lund University, Sweden)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube